04/10/2024
4:15 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:23 PM | Catalyst Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024
3:25 PM | Catalyst Pharmaceuticals (Filer)
| Form ARS | |
04/08/2024
1:03 PM | Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
3:45 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
2:01 PM | Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
4:01 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/28/2024
4:16 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
4:31 PM | Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
02/06/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
9:09 AM | Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024
4:15 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:10 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:23 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:15 PM | Catalyst Pharmaceuticals (Filer)
| Form 424B5 | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
12:47 PM | Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon’s New Device is About to Shock the World (Ad) Using this device you see above…
Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in…
“The next step in human evolution.”  Click here to see the details because there’s a lot of money at stake. |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
1:21 PM | Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
1:57 PM | Catalyst Pharmaceuticals (Subject)
GRANDE ALICIA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
11:54 AM | Catalyst Pharmaceuticals (Subject)
GRANDE ALICIA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/08/2023
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/07/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
11:48 AM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023
3:46 PM | Catalyst Pharmaceuticals (Subject)
Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/03/2023
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
7:15 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2023
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form ARS | |
07/12/2023
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form DEF 14A | |
06/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/30/2023
3:32 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
3:07 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
7:43 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
